Uterine Fibroid Embolization NYC

Do you Ask yourself if you have fibroids? Have you been looking for a fibroid specialist in New York? Uterine fibroids are very common, and most women with fibroids do not have symptoms, so they do not usually seek treatment. For this reason, most are detected by chance during a routine gynecological examination with ultrasound, which is the best technique for their detection.

fibroid specialist in NYC specializes in diagnosing and treating uterine fibroids. These doctors have extensive knowledge and expertise in evaluating the size, location, and characteristics of fibroids and determining the best course of treatment for each patient. If you have heavy periods, pain, or discomfort symptoms, seek a fibroid specialist in New York for personalized care and treatment options.

What is uterine fibroid embolization?

Uterine fibroids are usually asymptomatic and may be found incidentally on pelvic examination, sonogram, CT, or MRI. Treatment alternatives are sought when symptoms such as pain, pressure, and heavy bleeding, among others.

Fibroid doctors are trained to identify the different types of fibroids and their associated symptoms and proceed with uterine fibroid embolization in NYC. They may use various techniques to treat fibroids, such as medication, surgery, or non-invasive procedures. If you are experiencing fibroids symptoms, it is essential to consult with a qualified fibroid doctor to receive a proper diagnosis and treatment.

 Is uterine fibroid embolization in NYC a safe technique? 

UFE is not an experimental or investigational technique. Uterine fibroid embolization in NYC is performed on thousands of women worldwide. The embolization technique has been carried out since 1975, and uterine fibroids embolization has been carried out for more than 20 years with full safety guarantees.

Are there any contraindications to embolization?

The only contraindications shared by our fibroid specialist NYC are the existence of a pelvic infection or being pregnant, which is always ruled out before performing the embolization.

Is a fibroid specialist in New York an Interventional Radiologist?

The Interventional Radiologist is a fibroid specialist in NYC  with extensive experience in minimally invasive surgery guided by Radiology techniques (X-rays, ultrasound, CT). A fibroid specialist in New York has extensive experience performing uterine surgery such as myomectomies, hysterectomies, and laparoscopy, but not embolization. For this reason, they are often unaware of the excellent results of uterine fibroids embolization.

 What happens to fibroids after embolization?

Running out of blood, uterine fibroids gradually reduce in size and consistency. They convert from heavy, solid muscle tissue to lighter, spongy scar and reduce size. The rest of the uterus continues with blood flow through other vessels that reach it, so normal uterine tissue is unaffected.

What happens to the embolization particles inside my body?

The tiny particles of Embosphere acrylic used for uterine fibroid embolization become trapped in the fine vessels within the fibroid, where they cannot move or exit. These particles are entirely safe and innocuous, as the American (FDA) medical safety guarantees. They have been used for many years with complete safety in embolizations.

Are there some fibroids that cannot be treated with embolization?

Almost all uterine fibroids can be treated, with the great advantage that they treat multiple fibroids simultaneously if they exist. Only highly pedunculated fibroids, with a very thin pedicle, which remain as if hanging from the uterus, are best treated with laparoscopy or surgery.

How long does the intervention last? Hurts?

The entire technique of uterine fibroid embolization in NYC usually takes about an hour and a half. The anesthesia specialist will administer sedatives to make you sleep during the procedure. The process by fibroid specialists in New York does not require general anesthesia. It is performed with epidural anesthesia that usually lasts 24 hours. Discharge from the hospital takes place in 48-72 hours.

Consult our fibroid specialist in New York. Your health and well-being are our top priority. We’re confident that uterine fibroid embolization in NYC will be a positive and life-changing experience for you.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”